ADMA vs. ARQT
Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and Arcutis Biotherapeutics, Inc. (ARQT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ADMA or ARQT.
Correlation
The correlation between ADMA and ARQT is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ADMA vs. ARQT - Performance Comparison
Key characteristics
ADMA:
4.97
ARQT:
5.57
ADMA:
5.30
ARQT:
4.55
ADMA:
1.72
ARQT:
1.54
ADMA:
4.86
ARQT:
5.15
ADMA:
39.90
ARQT:
22.35
ADMA:
8.16%
ARQT:
21.42%
ADMA:
65.42%
ARQT:
85.91%
ADMA:
-91.28%
ARQT:
-95.02%
ADMA:
-23.08%
ARQT:
-59.46%
Fundamentals
ADMA:
$4.40B
ARQT:
$1.74B
ADMA:
$0.27
ARQT:
-$1.67
ADMA:
$382.81M
ARQT:
$138.71M
ADMA:
$186.78M
ARQT:
$124.04M
ADMA:
$98.48M
ARQT:
-$167.33M
Returns By Period
In the year-to-date period, ADMA achieves a 284.96% return, which is significantly lower than ARQT's 364.09% return.
ADMA
284.96%
-18.58%
58.18%
321.31%
32.75%
4.61%
ARQT
364.09%
47.25%
76.56%
476.54%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ADMA vs. ARQT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Arcutis Biotherapeutics, Inc. (ARQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ADMA vs. ARQT - Dividend Comparison
Neither ADMA nor ARQT has paid dividends to shareholders.
Drawdowns
ADMA vs. ARQT - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, roughly equal to the maximum ARQT drawdown of -95.02%. Use the drawdown chart below to compare losses from any high point for ADMA and ARQT. For additional features, visit the drawdowns tool.
Volatility
ADMA vs. ARQT - Volatility Comparison
The current volatility for ADMA Biologics, Inc. (ADMA) is 13.24%, while Arcutis Biotherapeutics, Inc. (ARQT) has a volatility of 23.51%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than ARQT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ADMA vs. ARQT - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Arcutis Biotherapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities